Search
for

    GlossaryRU58841

    non-steroidal anti-androgen researched for treating androgenic alopecia

    RU58841 is a non-steroidal anti-androgen that is often researched for its potential to treat androgenic alopecia (pattern hair loss). It works by binding to androgen receptors in the scalp, thereby preventing dihydrotestosterone (DHT) from attaching to these receptors and causing hair follicle miniaturization.

    Related Terms

    Learn

    2 / 2 results

      learn RU58841

      a potent but unapproved and potentially problematic topical anti-androgen

    Research

    5 / 478 results

    Community Join

    5 / 1000+ results

      community The story of RU58841/PSK3841

      in Research/Science 4 weeks ago
      RU58841, an anti-androgenic compound, showed early promise for treating alopecia but faced challenges after its patent in 1997. Despite advancing to Phase II trials, safety concerns and financial struggles led Aventis to abandon its development. Proskelia, which later merged into ProStrakan, couldn't prioritize the drug, leading to its eventual stagnation and failure to reach the market.
      The story of RU58841/ PSK3841

      community The story of RU58841/ PSK3841

      in Research  622 upvotes 4 weeks ago
      RU58841, a potential hair loss treatment, was not commercialized due to marketability issues and lack of long-term safety data. Concerns about its formulation and delivery methods further complicate its use.

      community Ru58841 after a hair transplant

      in Transplants  7 upvotes 1 month ago
      A user discussed their hair transplant progress and mentioned using 1mg Finasteride, 5% Topical Minoxidil, and recently starting 5% RU58841. They are seeking advice on whether to use RU58841 at month 4 post-transplant.